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A mimicked biosynthetic pathway of catechin metabolite genes from C. sinensis, consisting of ﬂavanone 3 hydroxylase (F3H),
dihydroﬂavonol reductase (DFR), and leucoanthocyanidin reductase (LCR), was designed and arranged in two sets of constructs:
(a) single promoter in front of F3H and ribosome-binding sequences both in front of DFR and LCR; (b) three diﬀerent promoters
with each in the front of the three genes and ribosome-binding sequences at appropriate positions. Recombinant E. coli BL
(DE3) harbouring the constructs were cultivated for 65h at 26◦C in M9 medium consisting of 40g/L glucose, 1mM IPTG, and
3mM eriodictyol. Compounds produced were extracted in ethyl acetate in alkaline conditions after 1h at room temperature and
identiﬁed by HPLC. Two of the four major catechins, namely, (−)-epicatechin (0.01) and (−)-epicatechin gallate (0.36mg/L), and
two other types ((+)-catechin hydrate (0.13mg/L) and (−)-catechin gallate (0.04mg/L)) were successfully produced.
1.Introduction
Catechins are synthesized from phenylalanine, an aromatic
amino acid (AAA) derived from the shikimate pathway,
[2]. Phenylalanine, a derivative of the shikimate pathway is
the ﬁrst metabolic node of the phenylpropanoid pathway.
The pathway is a metabolic tree with many branches
in which a plethora of phenolic compounds including
ﬂavonoids are synthesized. The study of Park et al. [1]o n
subtractive cDNA library and EST database in Camellia
sinensis (tea plant) showed a high- level expression of
primarily three genes, namely, F3H, DFR,a n dLCR encoding
ﬂavanone 3-hydroxylase, dihydroﬂavonol 4-reductase, and
leucoanthocyanidin reductase, in young leaves than in
mature leaves. The ﬁnding further proposes a biosynthetic
pathway of catechins. Chalcone synthase (CHSs) condenses
one molecule of 4-coumaryol-CoA and three molecules of
malonyl-CoA to produce a chalcone, which is later converted
into dihydroﬂavonol through a stereospeciﬁc hydroxylation
by F3H. Dihydroﬂavonol is then stereospeciﬁcally reduced
by DFR to result in leucoanthocyanin that is ﬁnally used as a
substratefortheproductionofcatechinsbytheactionofLCR
(Figure 1)[ 3]. Despite this extensive progress, attempts have
notbeenmadetomimicthepathwaytoprovetheproduction
of catechins in other hosts.
It is important to note that catechins have drawn a lot
of attention due to the variety of their properties. Among the
most studied properties are antioxidative [4], antiinﬂamma-
tory [5],antiobesity[6],andantidiabetic[7],justtomention
af e w .
The aforementioned properties of catechins have made
them potential functional ingredients in food stuﬀ and feed
stuﬀthatimprovethequalityoffoodproductswithincreased
shelf life [8]. These potentials have led to the development
of food products like tea beverages, cereal bars, as well as
ice creams, confectionaries and pet food that contain tea
as an active ingredient [9]. A number of methods have
been industrially developed by investigators to maximize
the content of catechins in food and drinks [10, 11], but
the sources of these substances have solely been from tea2 The Scientiﬁc World Journal
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Figure 1: The proposed pathways for the biosynthesis of catechins
in tea leaves. Enzymes are CHS: chalcone synthase; CHI: chalcone
isomerase; F3H: ﬂavanone 3-hydroxylase; DFR: dihydroﬂavonol
reductase;LCR:leucoanthocyanidinreductase.(AdoptedfromPark
et al. [1]).
leaves. One major drawback of these sources is its total
reliance on agriculture, which may result in shortages due to
unfavourable environmental conditions caused by the ever
changing climates.
It is worth highlighting that metabolic engineering
strategies have recently been developed for the standardized
biosynthesis of ﬂavonoids in the recombinant Saccharomyces
cerevisiae and Escherichia coli [12–16] by incorporating
genes in the biosynthetic pathway. To the researchers’ best
knowledge, none of the results have produced any of the four
primary catechins, but the potential for applying metabolic
engineering strategies exists for the synthesis of other natural
and nonnatural ﬂavonoids. Thus, the production of pure
catechins by E. coli strains carrying a cluster of F3H, DFR
and LCR from C. sinensis a n dc u l t i v a t e di nt h ep r e s e n c eo f
eriodictyol, a ﬂavanone, is presented in the current study.
2.Materials
2.1. Source and Handling of C. sinensis Leaves. Leaves were
collected from BOH Tea Plantation which is located in
Cameron Highlands, in Malaysia. The leaves were then
brought to the laboratory in clean polythene bags for
immediate analysis or otherwise stored in a freezer at −20◦C
for future use.
2.2. Strains, Plasmids, and Chemicals. E. coli strains (JM109
and BL21 (DE3)) were purchased from Fermentas (Mary-
land, USA) and plasmids pET26b, pET25b, and pUC18 were
purchased from Novagen (Merck KGaA, Darmstadt, Ger-
many). Ampicillin (50μg/mL) and Kanamycin (30μg/mL
and 5μg/mL) were used when necessary. X-gal and IPTG
were purchased from Nacalai Tesque (Kyoto, Japan) and
Fermentas, respectively. Eriodictyol was purchased from
Sigma (St. Louis, MO, USA). The restriction enzymes,
DNA ligation kit, genomic DNA puriﬁcation kit, GeneJET
plasmid Miniprep kit, bacterial transformation kit, and
IPTG were purchased from Fermentas, whereas KOD Hot
Start DNA polymerase was purchased from Novagen. All
other Chemicals were purchased from Merck (Darmstadt,
Germany) and are either of analytical or HPLC grade.
3. Methods
3.1. DNA Manipulation. C. sinensis genomic DNA was ex-
tracted from the leaves obtained from Cameron Highlands,
Malaysia, using standard methods [17]. The recombinant
DNA techniques were carried out as described by Sambrook
and Russell [18].
3.2. Construction of the Plasmids. Both plasmids (pET26b-
T7-3GS and pET26-rbs-3GS) were constructed using the
method proposed by Hwang et al. [14]a n dC h u ne ta l .[ 19].
Using the puriﬁed genomic DNA as a template, appropriate
primers (Table 1) were used to amplify the open reading
frames of the coding regions of F3 H, DFR, and LCR re-
sulting in 1107bp F3H (SacI/HindIII), 1044bp DFR
(SacI/HindIII),and1044bpLCR(KpnI/PstI)fragments.The
ampliﬁed fragments were cloned into the corresponding
sites on pUC-18 to form pUC-F3H, pUC-DFR and pUC-
LCR. The NdeI/EcoRI fragment derived from pUC-F3 H
was cloned into pET26b between NdeI/EcoRI to form
pET26b F3 H. Similarly, the KpnI/SalI and NdeI/XhoI
fragments, which had been derived from pUC-DFR and
pUC-LCR, respectively, were cloned into the corresponding
sites of pET25b to form pET25b-DFR and pET25b-LCR.
Using pET25b-DFR and pET25b-LCR as the templates,
the SacI/SalI (containing T7-rbs-DFR and/or rbs-DFR) and
SalI/XhoI (containing T7-rbs-LCR and/or rbs-LCR) frag-
ments were, respectively, derived. In order to construct
pET26b-T7-3GS or pET26-rbs-3GS, either T7-rbs-DFR and
T7-rbs-LCR or rbs-DFR and rbs-LCR were introduced
stepwise into pET26b-F3H (Figure 2).
3.3. Expression and Fermentation. Expression and fermenta-
tion conditions were carried out using the method proposed
by [14]. E. coli BL21(DE3) harbouring pET26b-rbs-3GS
and pET26b-PT7-3GS were precultured in Luria-Bertani
liquid medium containing 5μg of kanamycin/mL at 30◦C
for 16h with reciprocal shaking. Then, isopropyl β-D-
thiogalactopyranoside (IPTG) was added at the concentra-
tion of 1mM. After an incubation period of 2h at 26◦C,
the culture was prepared in an appropriate volume of 1X
SDS loading buﬀe ra n dh e a t e dt o1 0 0 ◦C for 3min. TheThe Scientiﬁc World Journal 3
Table 1: Primers used for the study.
Primer Name Sequences
F3H (SacI)-F GCG GAGCTC GAG ATG GCG CCA ACA ACA
F3H (HindIII)-R GAT AAGCTT ACA CTC TCA AGC AAA AAT CTC
DFR (SacI)-F GCGGAG CTCATC ATG AAA GAC TCT GTT
DFR (HindIII)-R GATAAGCTT TTA AAC CTT GTT GCC ATT
LCR (KpnI)-F GTA GGT ACC GCC ATG GCA ATG GCA ATG
LCR (PstI)-R GCG CTGCAG GTG CCT TCA GTT CTG CAA
F3H (NdeI)-F GCG CAT ATG GAG ATG GCG CCA ACA ACA
F3H (EcoRI)-R GAT GAA TTC ACA CTC TCA AGC AAA AAT CTC
DFR (KpnI)-F GCG CCATGG A T CA T GA A AG A CT C TG T T
DFR (SalI)-R GAT GTC GAC TTA AAC CTT GTT GCC ATT
LCR (NdeI)-F GTA CAT ATG GCC ATG GCA ATG GCA ATG
LCR (XhoI)-R GCG CTCGAG GTG CCT TCA GTT CTG CAA
SacI-T7-rbs-DFR-F GCGGAG CTC CGA TCC CGC GAA ATT AAT
SacI-T7-rbs-DFR-R GATGTC GAC TTA AAC CTT GTT GCC ATT
SacI−rbs-DFR-F AAC GAG CTC AAG AAG GAG TAT ACA TAT
SalI−rbs-DFR-R GAT GTC GAC TTA AAC CTT GTT GCC ATT
SacI-T7-rbs-LCR-F TCA GTC CGA TCC CGC GAA ATT AAT
Xhol-T7-rbs-LCR-R GCG CTCGAG GTG CCT TCA GTT CTG CAA
SalI−rbs-LCR-F AAC GTC GAC AAG AAG GAG TAT ACA TAT
XhoI−rbs-LCR-R GCG CTCGAG GTG CCT TCA GTT CTG CAA
∗Sequences in bold are restriction enzyme sites of degenerate primers.
SacI HindIII SacI HindIII KpnI PstI
SacI HindIII SacI HindIII KpnI PstI
NdeI EcoRI KpnI SalI NdeI XhoI
Ter Ter Ter
Ter
SacI SalI SalI XhoI
Ter
SacI SalI SalI XhoI
pUC-F3H
pET26b-F3H
pET26b-F3H
pET26b-T7-3GS
pET26b-F3H
pET26b-F3H
pET26b-rbs-3GS
pET26b-F3H
T7
T7
pUC-DFR
pET25b-DFR
T7-rbs-LCR
pET26b-DFR pET25b-LCR
RBS-DFR(SacI/SalI)
pET25b-DFR pET25b-LCR
LCR(KpnI/PstI)
pUC-LCR
pET25b-LCR
T7 T7 rbs rbs rbs
rbs
rbs
DFR(SacI/HindIII)
RBS-LCR(SalI/XhoI)
LCR(NdeI/XhoI)
F3H(SacI/HindIII)
F3H(NdeI/EcoRI) DFR(KpnI/SalI)
T7-rbs-DFR
Figure 2: Diagrammatic presentation of the constructs.4 The Scientiﬁc World Journal
EGCG
ECG
EC
EGC
CH
14 16 18 20
(min)
(a)
18 20 22 24
(min)
CG
(b)
Figure 3: (a) HPLC chromatograms of standard catechins (EC: (−)-epicatechin; ECG: (−)-epicatechin gallate; EGC: epigallocatechin;
EGCG: epigallocatechin gallate; CH: (+)-catechin Hydrate); (b) chromatogram of (−)-catechin gallate standard.
mixture was then loaded onto a sodium dodecyl sulphate
(SDS) polyacrylamide gel to analyze for total proteins [18].
In order to identify the compounds produced by E. coli
BL21 (DE3) harbouring pET26b-rbs-3GS and pET26b-PT7-
3GS, a portion (2mL) of the pre-culture was inoculated into
20mL of M9 medium (containing 10–40g/L glucose and
5μg of kanamycin/mL) and cultured for 5h at 26◦Ci nt h e
presence of diﬀerent concentrations of IPTG ranging from
0.25mM to 1mM. The cells were then harvested and a 50mg
(wet weight) portion of it was transferred into 20mL of
fresh M9 medium (containing 10–40g/L glucose and 5μg
of kanamycin/mL), IPTG (0.25mM to 1mM), eriodictyol
(3mM)) and cultivated at 26◦C for 65h with reciprocal
shaking.
3.4. Extraction and Analysis of Catechins. The extraction of
catechins was carried out using the method proposed by
Hwang et al. [14] .T h ep Ho fc u l t u r eb r o t hw a sa d j u s t e d
to pH 9.0 with 0.5M NaOH and allowed to stand at room
temperature for 1h. The compounds in the broth were then
extracted with 20mL of ethyl acetate. The organic layer was
evaporated at 40◦C using rotary evaporator (Eyela N1001,
Tokyo Rikakikai Co. Ltd), and the residue was dissolved in
30μL of methanol. The sample was analyzed using a high-
performance liquid chromatography (HPLC) Model, Jasco
CO-2065 Plus (Jasco Corporation, Japan) equipped with a
reversed phase C-18 Purospher Star column, PDA detector
with an acquisition wavelength set in the range of 200–
400nm and maintained at 40◦C and a ﬂow rate of 1mL/min.
The compounds were separated using a mobile phase with
water-acetic acid (97:3) as solvent A and methanol (solvent
B) by gradient elution. The mobile phase composition was
100% solvent A during the ﬁrst minute and gradually
decreased to 37% at 28min. The mobile phase composition
was then brought back to the initial conditions within
2min for the next run [20]. The peaks were identiﬁed by
comparing the retention times of the sample to those of
standards.
4. Results
Recombinant E. coli BL(DE3), carrying the gene clusters
(pET26b-T7-3GS and pET26-rbs-3GS) of the metabolite
genesofC.sinensisproducedtwoofthefourmajorcatechins,
namely, (−)-epicatechin (0.01mg/L) and (−)-epicatechin
gallate (0.36mg/L), in addition to (±)-catechin hydrate
(0.13mg/L) and (−)-catechin gallate (0.04mg/L) in alkaline
conditions (pH 9.0), after 1h at room temperature and
when cultivated at 26◦C in M9 medium consisting of 40g/L
glucose, 1mM IPTG, and 3mM eriodictyol, after 65h of
incubation with reciprocal shaking (Figure 4(a)). However,
thosecultureswhichwerenotsupplementedwitheriodictyol
did not produce catechins.
The results from SDS-PAGE produced bands of corre-
sponding theoretical sizes of the expected functional pro-
teins,namely,CsF3H(41.46kDa,368aa),CsDFR(38.69kDa,
347aa), and CsLCR (37.23kDa, 347aa), which were similar
to previously published results [21, 22]. These bands were
excised and identiﬁed through Peptide sequencing by mass
spectrometry.
The retention times of catechin standards used in this
study are shown in Figure 3 and were similar to the retention
times of the compounds produced during this study. The
retention times were 14.86, 17.68, 20.04, and 21.88min
for (+)-catechin hydrate, (−)-epicatechin, (−)-epicatechin
gallate, and (−)-catechin gallate, respectively (Figure 4(a)).
In addition, there were four other unidentiﬁed compounds
with retention times of 15.91, 18.02, 24.65, and 24.79min.
To determine the impacts of increased glucose concen-
tration, the cultures were cultivated in 3mM eriodictyol
and graded concentrations of glucose (10–40g/L) in M9The Scientiﬁc World Journal 5
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Figure 4: (a) Chromatogram of (±)-catechin hydrate (0.13mg/L), (−)-epicatechin (0.01mg/L), (−)-epicatechin gallate (0.36mg/L), and
(−)-catechingallate(0.04mg/L)inM9mediumsupplementedwith1mMIPTGand40g/Lglucoseand3mMeriodictyol;(b)chromatogram
of (±)-catechin hydrate (0.04mg/L), (−)-epicatechin (0.02mg/L), (−)-epicatechin gallate (0.04mg/L) in M9 medium supplemented with
1mM IPTG and 10g/L glucose and 3mM eriodictyol; (c) chromatogram of (−)-catechin gallate (0.05mg/L) and unknown compounds in
cultureswithoutIPTG;(d)chromatogramofbiosynthesized(−)-epicatechingallate,(0.08mg/L)inM9mediumsupplementedwith0.5mM
IPTG and 1mM eriodictyol; (e) chromatogram of (−)-epicatechin gallate (0.34mg/L) production at 1mM IPTG and 3mM eriodictyol in
M9 medium.6 The Scientiﬁc World Journal
minimal salts. Results showed an increase in the concen-
tration of (±)-catechin hydrate; from 0.04 to 0.13mg/L,
(−)-epicatechin gallate; 0.04 to 0.36mg/L and (−)-catechin
gallate; 0 to 0.04mg/L with increase in glucose concen-
tration from 10 to 40g/L. However, the concentration of
(−)-epicatechin was found to decrease (0.02 to 0.01mg/L)
with increase in glucose concentration (Figures 4(a) and
4(b)).
5. Discussion
This study demonstrates the production of (−)-epicatechin,
(−)-epicatechin gallate, (±)-catechin hydrate, and (−)-
catechin gallate using the recombinant strains of E. coli BL21
(DE3) cells carrying the metabolite genes of C. sinensis.
Meanwhile, several prior studies have shown C. sinensis as
one of the major sources of catechins [23]. Additionally, the
analysis of the genes has made deﬁned mRNA sequences,
including coding regions and open reading frames available
for references [21, 22]. Furthermore, the expression of these
genes, in relation to the concentration of catechins, has
been demonstrated as well [3, 24]. In the present study, the
proposed catechin biosynthetic pathway was adopted [1].
The successful production of these compounds has validated
the proposed pathway for catechin biosynthesis.
In line with the metabolic engineering approach, the
biosynthetic pathway was introduced into E. coli BL21 (DE3)
on a pET vector. It is crucial to note that E. coli BL21 (DE3)
lacks ompT (i.e., the outer membrane protease that degrades
protein during puriﬁcation) [25]. Therefore, to ensure a
selective and an active transcription of the genes of interest,
the pET vector which is controlled by a bacteriophage T7
promoter induced by IPTG and compatible to the host
was selected for use in the current study. Meanwhile,
perturbations were introduced in the form of a number of
promotersandribosome-bindingsequences.Inaddition,the
source of genes was from a homologous origin in contrast
to the previous studies which were comprised of heterol-
ogous clusters [12] to enhance the production the major
catechins found in C. sinensis. Contrary to the expectation
of producing all the major catechins, only two, namely,
(−)-epicatechin, (−)-epicatechin gallate, were produced in
addition to (±)-catechin hydrate and (−)-catechin gallate.
Studies in enzymology have indicated the suboptimum
pH for the activity of catechin biosynthetic enzymes to be 7.5
[26]. To enhance the activity of expressed gene products in
this study, the pH values of the cultures were changed from
an initial acidic condition to high alkanine conditions (pH
9.0) and allowed to stand for 1 hour. The decrease in the
productionof(−)-epicatechinisaccompaniedbyanincrease
intheamountofothercatechinsandthereasonforthistrend
is poorly understood.
The production of catechins by the recombinant strains
was possible in the absence of IPTG (Figure 4(c)). More-
over, there was a similarity in the retention times of
the unidentiﬁed compounds with that of IPTG-induced
cultures. The reason may be due to the basal expression
of T7 RNA polymerase gene in BL21 (DE3). As eriodictyol
and IPTG are expensive ingredients, the feasibility of using
these compounds for industrial production is therefore very
low. Nevertheless, the production of (−)-epicatechin gallate
(0.08mg/L) was possible at lower concentrations of 0.5mM
IPTG and 1mM eriodictyol (Figure 4(d)). Hence, the choice
of eriodictyol in this study was based on the substrate
speciﬁcity for the enzyme activity in ﬂavonoid biosynthesis,
as previously reported [26].
As reported previously, supplementation with glucose
leads to a reduction in the basal expression of lacUV5 pro-
moter in the T7 polymerase-based expression systems
through its inﬂuence on the level of cyclic adenosine
monophosphate (cAMP). It has also been suggested that
cAMP/CAP activator complexes increase the production of
T7 polymerase and thus initiate transcription in the long run
[27, 28]. Apparently, more of the diﬀerent catechins were
produced at higher glucose concentrations (Figure 4(a))
than that at the minimal levels (Figure 4(e)). This can
be attributed to increased recombinant plasmid stability
coupled with high target protein yield with increase in
glucose concentration which is in agreement with previous
reports [29].
The high contents of the various catechins obtained in
this study are in agreement with the previous enzymology
studies carried out on ﬂavonoid biosynthesis in C. sinensis
[26]. Apart from that, the presence of ribosome binding sites
(RBS), which facilitate the binding of mRNA and protein
translation [30], aids in the high expression of the three
genes. Moreover, the production of (−)-epicatechin and
(−)-epicatechin gallate is indication of the similarities of the
enzymaticbiosyntheticpathwaysofthetwocompoundswith
(±)-catechin hydrate and (−)-catechin gallate.
Thus, future research should focus on the isolation
of the identiﬁed compounds, as well as their potency
in relation to the previously reported functionalities. As
for the unidentiﬁed compounds, NMR will be used to
determine their structure and to ﬁnd out whether or not
theyarenewlyengineeredcompounds.Sincethefeasibilityof
using eriodictyol and IPTG for industrial production is not
economical at all, other genes will be cloned in the pathway
and arranged in a cluster to produce the precursors. The
possibility of using heterologous sources to produce major
catechins will also be explored.
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